Daniel L Gustafson

9PUBLICATIONS
39CO-AUTHORS
Solid tumoursVeterinary anaesthesiology and intensive carePredictive and prognostic markersMolecular targetsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 26, 2026
Comparative Response of Canine and Human Osteosarcoma Tumour Cell Lines to Molecularly Targeted Anticancer Agents at Clinically Relevant Exposures With Analysis of Genomic Biomarkers.

|Feb 16, 2026
The Pharmacokinetics of Intravenous and Subcutaneous Ondansetron in Female Beagle Dogs.

Elena D Landau, Kendal R Boege, Kristen Messenger

|Nov 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer.

Seth P Lerner, David J McConkey, Catherine M Tangen

|Sep 19, 2023
Sensitivity of osteosarcoma cell lines to autophagy inhibition as determined by pharmacologic and genetic manipulation.

Daniel L Gustafson, Lindsey O Viola, Christina G Towers

|Jul 24, 2023
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression.

Arthur R Wolin, Melanie Y Vincent, Taylor Hotz

|Jan 12, 2023
Vinblastine pharmacokinetics in mouse, dog, and human in the context of a physiologically based model incorporating tissue-specific drug binding, transport, and metabolism.

Sandra Witta, Keagan P Collins, Dominique A Ramirez

Pageof 2

Frequent Collaborators

3 joint publications

Dawn L Duval

2 joint publications

Sunetra Das

1 joint publications

Kristen Messenger

1 joint publications

Gregory Ballash